10x Genomics, Inc. TXG United States — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s united states — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s united states — revenue?
- 10x Genomics, Inc. (TXG) reported united states — revenue of $76.69M in Q1 2026.
- How has 10x Genomics, Inc.'s united states — revenue changed year-over-year?
- 10x Genomics, Inc.'s united states — revenue decreased by 11.7% year-over-year, from $86.82M to $76.69M.
- What is the long-term trend for 10x Genomics, Inc.'s united states — revenue?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s united states — revenue has grown at a 7.6% compound annual growth rate (CAGR), from $258.27M to $346.51M.
- What does united states — revenue mean?
- This metric represents the total revenue generated from sales of instruments, consumables, and software within the United States geographic market. It serves as a primary indicator of the company's market penetration and demand for life science technology solutions in its largest domestic region. Monitoring this figure helps investors assess regional growth trends and the effectiveness of local commercial operations.